Targeting the p53 cancer mutants Y220C, Y220N, and Y220S with the small-molecule stabilizer rezatapopt
Abstract The cavity-creating p53 cancer mutation Y220C, which accounts for an estimated 125,000 new cancer cases per year, serves as an excellent paradigm for the development of mutant p53 reactivators. Several molecules that reactivate this thermolabile cancer mutant by targeting the mutation-induc...
שמור ב:
| Principais autores: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2026-02-01
|
| סדרה: | Cell Death and Disease |
| גישה מקוונת: | https://doi.org/10.1038/s41419-026-08492-9 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|